Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay.

When observing theoretical MRD detection against observed in these spiking experiments, there was a highly significant degree of concordance between the two, with an established LoD level of 0.001%, although this dataset had a limit of reportable quantification of 0.003% ( Figure 1 , R 2 = 0.978, p < 0.01).

also in 132,142 other papers